• Study of cabozantinib with atezolizumab compared to sorafenib in untreated patients with advanced liver cancer (hepatocellular carcinoma)

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Hungary Romania Spain

  • Study of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany

  • Study of Dasatinib and Quercetin combination for treating liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Norucholic Acid for Treating Primary Sclerosing Cholangitis in Patients

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Denmark Finland France Germany Hungary +3

  • Study on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Finland France Germany Italy +3

  • Study on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant

    Not recruiting

    2 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Spain

  • Study of lenvatinib treatment benefits in patients with non-resectable liver cancer (hepatocellular carcinoma) who are on liver transplant waiting list after unsuccessful TACE therapy

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effects of Mycophenolate Mofetil and Prednisolone in Patients with Chronic Virus-Negative Inflammatory Cardiomyopathy

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study on Dalbavancin and Rifampicin for Treating Prosthetic Joint Infections in Patients with Hip, Knee, and Shoulder Replacements

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

powered by